Ensartinib in Resected <em>ALK</em>-Positive Non-Small-Cell Lung Cancer
Listen to this summary
This study investigates the safety and efficacy of ensartinib, a second-generation ALK inhibitor, in patients with completely resected ALK-positive non-small-cell lung cancer (NSCLC) following adjuvant chemotherapy. The results demonstrate that ensartinib significantly improves disease-free survival at 24 months compared to placebo, with 86.4% of patients in the ensartinib group remaining disease-free versus 53.5% in the placebo group. The findings suggest that ensartinib may be a promising treatment option for this patient population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The New England journal of medicine
View all →Jul 8, 2026 · The New England journal of medicine
Nutrition Therapy in Critically Ill Adults
Jul 8, 2026 · The New England journal of medicine
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
Jul 8, 2026 · The New England journal of medicine
Meningococcal B Vaccine to Prevent <em>Neisseria gonorrhoeae</em> Infection
Jul 1, 2026 · The New England journal of medicine
Advances in Multiple Sclerosis
Jul 1, 2026 · The New England journal of medicine
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Jul 1, 2026 · The New England journal of medicine
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis
More in Obstetrics & Gynecology
View all →Jul 11, 2026 · Gynecologic oncology reports
Impact of patient neighborhood area deprivation index on prognostic factors and outcomes in endometrioid adenocarcinoma of the endometrium: a retrospective multi-center healthcare network analysis
Jul 11, 2026 · Gynecologic oncology reports
Leveraging artificial intelligence to streamline documentation and support patient-centered gynecologic oncology outpatient visits
Jul 10, 2026 · BMC women's health
Association of TGFA gene polymorphisms (rs11466297 and rs3732248) with polycystic ovary syndrome (PCOS): a case-control study
Jul 10, 2026 · BMC women's health
Integrating epigenetic and metabolic indicators for non-invasive endometrial cancer triage: a machine learning approach
Jul 10, 2026 · International urogynecology journal
Vesico-Vaginal Fistula Repair Using Pneumovesicoscopy: A Single Tertiary Care Center Study
Jul 10, 2026 · BMC women's health
The relationship between women's occupation and fertility outcomes in The Gambia, 2019-2020
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


